BLTE
Belite Bio Inc ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$164.11
-5.44 ▼ -3.21%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$164.11
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -2.3 | Insider Own | 0.86% | Shs Outstand | 0.04B | Perf Week | -5.3% |
| Market Cap | 6.46B | Forward P/E | 126.73 | EPS next Y | 160.44% | Insider Trans | - | Shs Float | 0.04B | Perf Month | -6.25% |
| Enterprise Value | 5.68B | PEG | - | EPS next Q | -0.64 | Inst Own | 18.39% | Short Float | 2.03% | Perf Quarter | 11.65% |
| Income | -0.08B | P/S | - | EPS this Y | 7.25% | Inst Trans | 5.57% | Short Ratio | 3.67 | Perf Half Y | 139.4% |
| Sales | 0.00B | P/B | 8.38 | EPS next 5Y | - | ROA | -16.64% | Short Interest | 0.79M | Perf YTD | 2.59% |
| Book/sh | 19.59 | P/C | 8.36 | EPS past 3/5Y | -54.04% -549.64% | ROE | -16.94% | 52W High | -17.94% ($200.00) | Perf Year | 136.18% |
| Cash/sh | 19.64 | P/FCF | - | Sales past 3/5Y | - | ROIC | -28.32% | 52W Low | 234.92% ($49.00) | Perf 3Y | 429.39% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -94.37% | Gross Margin | - | Volatility(W/M) | 5.17% 4.86% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 9.11 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 24.31 | EPS Q/Q | -117.75% | Profit Margin | - | RSI (14) | 40.88 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 24.31 | Sales Q/Q | - | SMA20 | -7.74% ($177.88) | Beta | -1.34 | Target Price | $211.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -4.02% ($170.98) | Rel Volume | 0.51 | Prev Close | $169.55 |
| Employees | 25 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 30.44% - | SMA200 | 52.06% ($107.92) | Avg Volume(3M) | 0.22M | Price | $164.11 |
| IPO | 2022/4/29 | Option/Short | No/Yes | Trades | 2809 | Volume | 109,758 | Change | -3.21% |
뉴스 로딩 중...